Chenyang Shi
Direttore/Membro del Consiglio presso GENSCRIPT BIOTECH CORPORATION
Profilo
Chenyang Shi was the founder of NuProbe USA, Inc., a company founded in 2016, where he held the title of Chief Executive Officer.
He is currently working as an Independent Non-Executive Director at Genscript Biotech Corp.
since 2024.
Dr. Shi has a graduate and doctorate degree from Rochester Christian University.
He also holds an undergraduate degree from the University of Science & Technology of China, which he received in 1986.
Posizioni attive di Chenyang Shi
| Società | Posizione | Inizio |
|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Direttore/Membro del Consiglio | 12/04/2024 |
Precedenti posizioni note di Chenyang Shi
| Società | Posizione | Fine |
|---|---|---|
NuProbe USA, Inc.
 NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Fondatore | - |
Formazione di Chenyang Shi
| Rochester Christian University | Doctorate Degree |
| University of Science & Technology of China | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENSCRIPT BIOTECH CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
NuProbe USA, Inc.
NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Chenyang Shi
